Skip to content

Inogen INGN Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount at other companies

Popular logo
PopularBPOP
$2M
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$30.63M+6.2%
Solidion Technology, Inc. logo
Solidion Technology, Inc.STI
-$741.86K-438%
Silvaco Group, Inc. logo
Silvaco Group, Inc.SVCO
$1.35M-15.6%
American Coastal Insurance Corporation logo
American Coastal Insurance CorporationACIC
$4.45M+101%
iHeartMedia, Inc. logo
iHeartMedia, Inc.IHRT
$23.43M+106%

Other financials

Income statement

See full
Revenue$85.1M+3.4%
Gross profit$44.9M+1.7%
Operating income-$9.3M-21.9%
Net income-$8.3M-34.8%
EPS (diluted)-$0.30-20.0%

Balance sheet

See full
Cash & equivalents$93.1M-21.7%
Total debt$16.9M-11.9%
Total equity$182.9M-7.6%
Total assets$285.9M-7.3%

Cash flow

See full
Operating cash flow-$6.7M+60.2%
CapEx$210.0K-28.1%
Free cash flow-$6.9M+59.6%

Valuation

See full
Market cap$174.63M-9.7%
Enterprise value$98.45M-9.5%
P/S0.5×-0.1×

Profitability

See full
Gross margin52.8%-2.6pp
Operating margin-9.1%-0.8pp
Net margin-7.1%-0.8pp
FCF margin0.4%

Returns & leverage

See full
Return on equity-13.1%-0.9pp
Debt / equity0.1×0.0×
Current ratio3.1×0.0×

Where this comes from

Reported directly by Inogen in its filing.

Tagged under the XBRL concept us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount.

The official record: Inogen’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inogen's valuation allowance, deferred tax asset, increase (decrease), amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inogen's valuation allowance, deferred tax asset, increase (decrease), amount?
Inogen (INGN) reported valuation allowance, deferred tax asset, increase (decrease), amount of $985.25K in Q4 2025.
How has Inogen's valuation allowance, deferred tax asset, increase (decrease), amount changed year-over-year?
Inogen's valuation allowance, deferred tax asset, increase (decrease), amount decreased by 40.0% year-over-year, from $1.64M to $985.25K.
What is the long-term trend for Inogen's valuation allowance, deferred tax asset, increase (decrease), amount?
Over 3 years (2022 to 2025), Inogen's valuation allowance, deferred tax asset, increase (decrease), amount has grown at a -45.6% compound annual growth rate (CAGR), from $24.51M to $3.94M.
What does valuation allowance, deferred tax asset, increase (decrease), amount mean?
This metric tracks the net change in the valuation allowance established against deferred tax assets. An increase in the allowance suggests management's reduced confidence in the ability to realize future tax benefits from net operating losses or other credits. It is a key indicator of the company's outlook on future taxable income and tax asset recoverability.